MedTrace Logo

Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations

NCT06429644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4010

Last updated 2024-05-28

No results posted yet for this study

Summary

The investigators matched BCS and mastectomy group using propensity scores and analyzed the recurrence and survival among the evenly matched patients in breast cancer patients with BRCA 1/2 mutations.

Conditions

  • BRCA1/2 Mutation
  • Breast-conserving Surgery

Interventions

PROCEDURE

Breast-conserving surgery

Breast-conserving surgery, also known as breast-conserving therapy or lumpectomy, is a surgical procedure used to treat breast cancer while preserving as much of the breast tissue as possible. During this procedure, the surgeon removes the cancerous tumor along with a surrounding margin of normal tissue. The goal is to remove the cancerous cells while maintaining the appearance and function of the breast as much as possible.

Sponsors & Collaborators

  • Korean Surgical Society

    collaborator UNKNOWN

  • Korea Robot-Endoscopy Minimal Access Breast Surgery Study Group

    collaborator UNKNOWN

  • Hanyang University Seoul Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-07
Primary Completion
2023-12-31
Completion
2024-04-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06429644 on ClinicalTrials.gov